Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 08:34 am Sale | 13G | Global Blood Therapeutics Inc. GBT | Deep Track Capital LP | 0 0.000% | -3,646,690 (Position Closed) | View |
| 2023-02-09 10:59 am Sale | 13G | Global Blood Therapeutics Inc. GBT | FMR LLC | 278,419 0.410% | -4,318,972 (-93.94%) | View |
| 2022-06-17 4:04 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | Deep Track Capital LP | 3,646,690 5.600% | 3,646,690 (New Position) | View |
| 2022-02-14 4:46 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | Point72 Asset Management L.P. | 225,463 0.300% | -2,999,111 (-93.01%) | View |
| 2022-02-14 4:14 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | BAKER BROS. ADVISORS LP | 3,314,765 5.100% | 3,314,765 (New Position) | View |
| 2022-02-14 3:50 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | PERCEPTIVE ADVISORS LLC | 3,449,915 5.400% | -2,224,796 (-39.21%) | View |
| 2022-02-14 2:34 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | PRICE T ROWE ASSOCIATES INC | 3,260,685 5.000% | -802,438 (-19.75%) | View |
| 2022-02-10 4:06 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 5,483,164 8.500% | -789,518 (-12.59%) | View |
| 2022-02-10 08:11 am Purchase | 13G | Global Blood Therapeutics Inc. GBT | VANGUARD GROUP INC | 5,993,142 9.300% | 532,660 (+9.75%) | View |
| 2022-02-09 09:19 am Purchase | 13G | Global Blood Therapeutics Inc. GBT | FMR LLC | 4,597,391 7.099% | 3,370,553 (+274.73%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | BlackRock Inc. BLK | 5,353,056 8.300% | 1,669,796 (+45.33%) | View |
| 2022-01-31 3:15 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | BANK OF AMERICA CORP BAC | 1,603,685 2.500% | -4,279,893 (-72.74%) | View |
| 2021-10-12 12:47 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 6,272,682 10.100% | 305,820 (+5.13%) | View |
| 2021-05-13 4:34 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | Point72 Asset Management L.P. | 3,224,574 5.200% | 2,797,541 (+655.11%) | View |
| 2021-05-10 1:11 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | FMR LLC | 1,226,838 1.970% | -3,180,227 (-72.16%) | View |
| 2021-02-16 3:35 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | PERCEPTIVE ADVISORS LLC | 5,674,711 9.200% | -191,015 (-3.26%) | View |
| 2021-02-16 12:23 pm Sale | 13G | Global Blood Therapeutics Inc. GBT | PRICE T ROWE ASSOCIATES INC | 4,063,123 6.500% | -1,593,062 (-28.16%) | View |
| 2021-02-12 3:25 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 5,966,862 9.700% | 3,443,594 (+136.47%) | View |
| 2021-02-10 10:57 am Sale | 13G | Global Blood Therapeutics Inc. GBT | VANGUARD GROUP INC | 5,460,482 8.840% | -10,980 (-0.20%) | View |
| 2021-02-08 5:14 pm Purchase | 13G | Global Blood Therapeutics Inc. GBT | BANK OF AMERICA CORP BAC | 5,883,578 9.500% | 1,185,435 (+25.23%) | View |